Get the Stockscreener App
5.14
3.84%
+0.19
Exscientia Plc ADR stock is currently priced at $5.14, with a 24-hour trading volume of 717.40K.
It has seen a +3.84% increased in the last 24 hours and a -5.34% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $4.92 pivot point. If it approaches the $5.21 resistance level, significant changes may occur.
Previous Close:
$4.95
Open:
$5
24h Volume:
717.40K
Market Cap:
$649.57M
Revenue:
$25.81M
Net Income/Loss:
$-188.12M
P/E Ratio:
-3.5441
EPS:
-1.4503
Net Cash Flow:
$-183.77M
1W Performance:
+24.46%
1M Performance:
-5.34%
6M Performance:
-3.02%
1Y Performance:
+4.90%
1D Range:
$4.70
$5.2299
52W Range:
$3.86
$9.12
Exscientia Plc ADR Stock (EXAI) Company Profile
Name
Exscientia Plc ADR
Sector
Industry
Phone
44 13 8220 2136
Address
The Schrödinger Building, Oxford Science Park, Oxford
Exscientia Plc ADR Stock (EXAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-24 | Downgrade | BofA Securities | Buy → Neutral |
Exscientia Plc ADR Stock (EXAI) Latest News
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Brian's Big Idea on Healthcare
Zacks Investment Research
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Wall Street Analysts See a 67.76% Upside in Exscientia PLC Sponsored ADR (EXAI): Can the Stock Really Move This High?
Zacks Investment Research
Exscientia Plc ADR Stock (EXAI) Financials Data
Exscientia Plc ADR (EXAI) Revenue 2024
EXAI reported a revenue (TTM) of $25.81 million for the quarter ending December 31, 2023, a -26.27% decline year-over-year.
Exscientia Plc ADR (EXAI) Net Income 2024
EXAI net income (TTM) was -$188.12 million for the quarter ending December 31, 2023, a -25.84% decrease year-over-year.
Exscientia Plc ADR (EXAI) Cash Flow 2024
EXAI recorded a free cash flow (TTM) of -$183.77 million for the quarter ending December 31, 2023, a -83.06% decrease year-over-year.
Exscientia Plc ADR (EXAI) Earnings per Share 2024
EXAI earnings per share (TTM) was -$1.4747 for the quarter ending December 31, 2023, a -26.51% decline year-over-year.
About Exscientia Plc ADR
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
3.18%
Cap:
|
Volume (24h):